Maudsley Guidelines on Advanced Prescribing in Psychosis

Regular price €26.50
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery

Guide to prescribing for psychosis

A01=David M. Taylor
A01=Paul Morrison
A01=Phillip McGuire
Age Group_Uncategorized
Age Group_Uncategorized
antipsychotics
Author_David M. Taylor
Author_Paul Morrison
Author_Phillip McGuire
automatic-update
bipolar disorder
Category1=Non-Fiction
Category=MKLD
Category=MMH
Category=MMJ
controlled trials for drugs for psychosis
COP=United Kingdom
Delivery_Delivery within 10-20 working days
eq_isMigrated=2
eq_nobargain
Language_English
neurotransmitters and receptors

PA=Available
pharmacology of psychosis
Price_€20 to €50
PS=Active
softlaunch
text on prescribing for psychosis
understanding prescribing for psychosis

Product details

  • ISBN 9781119578444
  • Weight: 227g
  • Dimensions: 188 x 234mm
  • Publication Date: 30 Jan 2020
  • Publisher: John Wiley and Sons Ltd
  • Publication City/Country: GB
  • Product Form: Paperback
  • Language: English
Secure checkout Fast Shipping Easy returns

A guide to treating psychosis that provides information on drug options and side-effects in order to allow for weighing treatment options knowledgably

The Maudsley Guidelines on Advanced Prescribing in Psychosis offers a resource that puts the focus on the need to treat the individual needs of a patient. The authors – noted experts on the topic – offer an alternative to the one-size-fits-all treatment of psychosis and shows how to build psychiatrist and patient relationships that will lead to effective individual treatment plans.

The book provides up-to-date data and information about commonly used anti-psychotic drugs and drugs used in bipolar disorder. The text weighs both the upsides and downsides of each pharmaceutical presented, and helps prescribers and patients weigh the costs and benefits of various options to reach an appropriate treatment plan. The authors highlight the treatment at a population level and the systems in which individual treatments take places. This important resource:

  • Facilitates the tailoring of an appropriate treatment plan for clients manifesting signs of psychosis
  • Offers a comparative strategy that helps gauge the suitability of one treatment plan over another
  • Provides at-hand data and information about commonly used anti-psychotic drugs
  • Includes an understanding of the origins and side-effects of each drug presented

The Maudsley Guidelines on Advanced Prescribing in Psychosis offers psychiatrists and other mental health practitioners an essential guide for treating psychosis on an individualized level.

Paul Morrison, PhD, FRCPsych., is a consultant psychiatrist in Argyll and Bute Hospital, Scotland, UK. He is also an honorary Clinical senior lecturer in psychopharmacology at the Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

David M. Taylor, PhD, FRPharmS, is Director of Pharmacy and Pathology at the Maudsley Hospital and is Professor of Psychopharmacology at King's College London, London, UK.

Phillip McGuire, PhD, is a professor of Psychiatry and Cognitive Neuroscience and head of the Department of Psychosis Studies at the Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

More from this author